Home Menu

Site Navigation



ALS News & Research For postings of news or research links and articles related to ALS


advertisement
NeuroTalk Support Groups > > > >

Global neurodegenerative drugs market set to hit $45 billion by 2022

Reply
 
Thread Tools Display Modes
Old 12-07-2016, 03:38 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,266
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
Exclamation Global neurodegenerative drugs market set to hit $45 billion by 2022
Global neurodegenerative drugs market set to hit $45 billion by 2022

Global neurodegenerative drugs market set to hit $45 billion by 222
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Old 12-07-2016, 03:40 PM #2
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,266
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
Exclamation AL-S Pharma created to develop innovative therapy for ALS
AL-S Pharma created to develop innovative therapy for ALS

AL-S Pharma created to develop innovative therapy for ALS
MuonOne is offline   Reply With QuoteReply With Quote
Old 12-07-2016, 03:41 PM #3
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,266
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
Exclamation Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop I
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS

Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
MuonOne is offline   Reply With QuoteReply With Quote
Old 12-07-2016, 03:43 PM #4
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,266
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
Exclamation Neurimmune, TVM set up ALS biotech, secure support of Eli Lilly unit for advance towa
Neurimmune, TVM set up ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept

Neurimmune, TVM set up ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept | FierceBiotech
MuonOne is offline   Reply With QuoteReply With Quote
Reply

Tags
$45, billion, drugs, hit, neurodegenerative

« Previous Thread | Next Thread »
Thread Tools
Display Modes
Linear Mode Linear Mode

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Patents Expiring Will Propel Growth of Generics In Neurodegenerative Drugs Market BobbyB ALS News & Research 0 08-12-2007 08:08 AM
The Wheelchair & Scooter Market is Expected to Grow to $5.3 billion by 2012 BobbyB ALS 0 12-14-2006 01:29 PM


All times are GMT -5. The time now is 01:23 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home